Pfenex Reports Second Quarter 2015 Results and Provides Business Update

Go back to Pfenex Reports Second Quarter 2015 Results and Provides Business Update

Pfenex (PFNX) PT Lifted to $22 at Mizuho Securities; Clearer Approval Path

August 13, 2015 1:18 PM EDT

Mizuho Securities analyst Peter Lawson reiterated a Buy rating and raised his price target on Pfenex Inc. (NYSE: PFNX) to $22.00 (from $18.00) following Q2 results and a clearer approval path.

Lawson commented, "We have increased the probabilities of success for PF502 and PF530... More

Pfenex (PFNX) Tops Q2 EPS by 12c

August 13, 2015 7:47 AM EDT

Pfenex (NYSE: PFNX) reported Q2 EPS of ($0.27), $0.12 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $2.07 million.

For earnings history and earnings-related data on Pfenex (PFNX) click here.

... More